"A Phase 3B, Randomized, Double-Blind Clinical Trial to Evaluate the Efficacy and Safety ofAbatacept SC in Combination with Methotrexate Compared to Methotrexate Monotherapy in Achieving Clinical Remission in Adults with Early Rheumatoid Arthritis who are Methotrexate Naive"

drug protocol number
IM101550
drug sponsor
Bristol-Myers Squibb
drug study
Abatacept
drug trial site
King Fahad Medical City (Riyadh)
drug status
Terminated
drug phase